TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9876348

Group type: EXPERIMENTAL
Intervention: Naloxone (4 mg i.v.)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline (as control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both interventions (Naloxone and Saline)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v.)
Number of subjects: 11
Study: 8031733

Group type: EXPERIMENTAL
Intervention: 1 MJ meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 2 MJ meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 3 MJ meal
Number of subjects: 8
Study: 2597607

Group type: EXPERIMENTAL
Intervention: Imotest multiple puncture tuberculin test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heaf test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mantoux test
Number of subjects: 0
Study: 30060030

Group type: EXPERIMENTAL
Intervention: Talc pleurodesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indwelling pleural catheters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LENT score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brims' prognostic score
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oncological therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tissue biopsy
Number of subjects: 0
Study: 28927917

Group type: EXPERIMENTAL
Intervention: Active leisure contact sports (group A)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Matched controls (group B)
Number of subjects: 204
Study: 25619410

Group type: EXPERIMENTAL
Intervention: Azilsartan medoxomil (AZL‐M) 40 mg once a day (QD), titrated to 80 mg at week 4, with optional addition of chlorthalidone (CLD) 25 mg QD (weeks 8-22) if required.
Number of subjects: 418

Group type: COMPARATOR
Intervention: Azilsartan medoxomil (AZL‐M)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 23789212

Group type: EXPERIMENTAL
Intervention: Perilla oil treatment for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 21971472

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18653347

Group type: EXPERIMENTAL
Intervention: Stand-alone interbody cage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Autologous iliac bone grafting with anterior plate
Number of subjects: 0
Study: 16645290

Group type: EXPERIMENTAL
Intervention: Semi-standardized acupuncture (12 sessions, 6 predefined basic points, optional additional points)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Standardized minimal acupuncture (superficial needling of at least 5 of 10 predefined, distant non-acupuncture points)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 302
Study: 14639962

Group type: EXPERIMENTAL
Intervention: Sufficient sleep
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Heavy smoking
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Drinking
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Knowledge about the harm of smoking
Number of subjects: 2000
Study: 10682965

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1-year use of dorzolamide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 19
Study: 9015905

Group type: EXPERIMENTAL
Intervention: Nasal surgery with nasal pack removed after two hours
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nasal surgery with longer duration of nasal packing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Submucosal resection group
Number of subjects: 90
Study: 1721574

Group type: EXPERIMENTAL
Intervention: Attention effect (Md) for 1 kHz tones
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Attention effect (Md) for 3 kHz tones
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Attention effect (Md) in experiment 2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Location of Md source
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Modification of exogenous evoked response components
Number of subjects: 23
Study: 6343164

Group type: EXPERIMENTAL
Intervention: Jejunoileal bypass surgery
Number of subjects: 34
Study: 31525581

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 21
Study: 28262499

Group type: EXPERIMENTAL
Intervention: Group 1 (G1) - 2 hours of training
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Group 2 (G2) - 1 hour of training
Number of subjects: 9

Group type: COMPARATOR
Intervention: Group 3 (G3) - no practical training
Number of subjects: 9
Study: 25186180

Group type: EXPERIMENTAL
Intervention: Escherichia‐coli‐produced recombinant human bone morphogenetic protein 2 (ErhBMP‐2) with a biphasic calcium phosphate (BCP) carrier
Number of subjects: 41

Group type: COMPARATOR
Intervention: Deproteinized bovine bone
Number of subjects: 41
Study: 24477367

Group type: EXPERIMENTAL
Intervention: Partly covered antireflux metal stents (pcARMS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard uncovered self‐expandable metal stents (ucSEMS)
Number of subjects: 112
Study: 21950578

Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sodium valproate 400 mg/day
Number of subjects: 56
Study: 19679275

Group type: EXPERIMENTAL
Intervention: Surgical treatment for FCD type II
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug treatment for FCD type II
Number of subjects: 0
Study: 17294225

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 31

Group type: COMPARATOR
Intervention: Methylprednisone
Number of subjects: 31
Study: 15026437

Group type: EXPERIMENTAL
Intervention: Free smoke alarm installation
Number of subjects: 0
Study: 11573916

Group type: EXPERIMENTAL
Intervention: Wrist protectors (braced group)
Number of subjects: 5029

Group type: COMPARATOR
Intervention: Control group (no wrist protectors)
Number of subjects: 5029
Study: 9043731

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate (12.5, 25, 50, or 100 mg)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study: 7911057

Group type: EXPERIMENTAL
Intervention: Bunazosin 3 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bunazosin 6 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bunazosin 12 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bunazosin (all doses)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3328105

Group type: EXPERIMENTAL
Intervention: Large doses of Prednisone (3960 mg over 54 days, initial dose 200 mg per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medium doses of Prednisone (initial dose 60 mg)
Number of subjects: 0
Study: 29921942

Group type: EXPERIMENTAL
Intervention: Virtual Non-Contrast (VNC)-CT
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional CT (CT)
Number of subjects: 29
Study: 27119427

Group type: EXPERIMENTAL
Intervention: Retrograde autologous priming (RAP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional CPB (priming with suspended red blood cells, plasma and albumin)
Number of subjects: 60
Study: 24462581

Group type: EXPERIMENTAL
Intervention: Disulfiram 250mg daily
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 24065295

Group type: EXPERIMENTAL
Intervention: High-density catechins
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-density catechins
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 20005081

Group type: EXPERIMENTAL
Intervention: Selective serotonin-reuptake inhibitors (SSRIs) for 52 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 10
Study: 17498312

Group type: EXPERIMENTAL
Intervention: Cooling method based on conduction, namely immersion in iced water
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Non‐invasive, evaporative, or conductive‐based cooling techniques
Number of subjects: 556

Group type: COMPARATOR
Intervention: Cooling techniques (various)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Cooling techniques
Number of subjects: 556

Group type: COMPARATOR
Intervention: Circulatory alterations in heatstroke
Number of subjects: 556

Group type: COMPARATOR
Intervention: Myocardial failure
Number of subjects: 556
Study: 15354980

Group type: EXPERIMENTAL
Intervention: Intermittent hirudin (initial bolus application of 2-2-5 microg/kg, adjusted in 2 microg/kg bolus steps)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Continuous heparin (250 IU/h, adjusted in 125 IU/h steps)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Continuous heparin
Number of subjects: 26
Study: 11543749

Group type: EXPERIMENTAL
Intervention: Drotaverine hydrochloride
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Valethamate bromide
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 150
Study: 9924221

Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine with fentanyl
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.25% bupivacaine
Number of subjects: 0
Study: 7918131

Group type: EXPERIMENTAL
Intervention: Acadesine 6 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acadesine 12 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acadesine 24 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acadesine 48 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2843201

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Enalapril (all doses)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29722468

Group type: COMPARATOR
Intervention: Catheter ablation (CA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Convergent epicardial and endocardial ablation procedure (CVP)
Number of subjects: 50
Study: 27749754

Group type: EXPERIMENTAL
Intervention: OTO‐104 (12 mg dexamethasone)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 24750029

Group type: EXPERIMENTAL
Intervention: Peel-off facial mask with 5% w/w soybean extract fermented by Bifidobacterium animale
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oil-in-water emulsion
Number of subjects: 0
Study: 23820656

Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 160

Group type: COMPARATOR
Intervention: Monopolar TURP
Number of subjects: 160
Study: 21227010

Group type: EXPERIMENTAL
Intervention: 1.6 mg active TA(1)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 1.6 mg recombinant TA(1)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 3.2 mg recombinant TA(1)
Number of subjects: 25
Study: 19108666

Group type: EXPERIMENTAL
Intervention: Paroxetine monotherapy
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combination paroxetine-divalproex sodium therapy
Number of subjects: 9
Study: 16757447

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral body image therapy
Number of subjects: 30
Study: 15291906

Group type: EXPERIMENTAL
Intervention: Anti-IgE monotherapy
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: SIT and anti-IgE combined treatment
Number of subjects: 221

Group type: COMPARATOR
Intervention: SIT grass pollen monotherapy
Number of subjects: 221

Group type: COMPARATOR
Intervention: SITbirch + placebo
Number of subjects: 221
Study: 11211468

Group type: EXPERIMENTAL
Intervention: Laser therapy (transmyocardial revascularization and percutaneous myocardial revascularization)
Number of subjects: 0
Study: 9767511

Group type: EXPERIMENTAL
Intervention: Urethral catheterization (UC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Suprapubic bladder aspiration (SPA)
Number of subjects: 33
Study: 7908256

Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carvedilol 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3276296

Group type: EXPERIMENTAL
Intervention: Drainage after thyroid surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: No drainage after thyroid surgery
Number of subjects: 150
Study: 31578889

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (10 weeks, 10 to 12 sessions, using 19-channel EEG, training parameters based on each child's peak alpha frequency)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 48
Study: 31503028

Group type: EXPERIMENTAL
Intervention: Stabilization exercises along with self-care training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Self-care training
Number of subjects: 32
Study: 29042376

Group type: EXPERIMENTAL
Intervention: Managed transition using the Transition Readiness and Appropriateness Measure score summary as a decision aid
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Managed transition
Number of subjects: 1050
Study: 26572788

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated prevention programs (NCPP)
Number of subjects: 13
Study: 23601463

Group type: EXPERIMENTAL
Intervention: Calf blood extract gel
Number of subjects: 12

Group type: COMPARATOR
Intervention: Autologous serum
Number of subjects: 12
Study: 21601979

Group type: EXPERIMENTAL
Intervention: N-Palmitoylethanolamine-transpolydatin 400 mg + 40 mg twice a day for 3 months
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice a day for 7 consecutive days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 61
Study: 19843672

Group type: EXPERIMENTAL
Intervention: TACE sheddase activity measurement in HNC tissues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: siRNA silencing of TACE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TACE protein expression measurement
Number of subjects: 0
Study: 16388198

Group type: EXPERIMENTAL
Intervention: Hydrophobic acrylic IOLs (Acrysof; Alcon)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Plate-haptic silicone IOLs (C11UB; Chiron, Bausch & Lomb)
Number of subjects: 26
Study: 12623938

Group type: EXPERIMENTAL
Intervention: DASH diet (DASH‐CD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low‐antioxidant diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 24
Study: 11030277

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 400 microg/day
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fluticasone proprionate (FP) 200 microg/day
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (sodium cromoglycate and beta2-agonist)
Number of subjects: 26
Study: 9115051

Group type: EXPERIMENTAL
Intervention: Oxaprozin 1200 mg once daily
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg once daily
Number of subjects: 52
Study: 8382588

Group type: EXPERIMENTAL
Intervention: 450mg lithium carbonate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 600mg lithium carbonate
Number of subjects: 12

Group type: COMPARATOR
Intervention: dopamine infusion
Number of subjects: 12
Study: 3730525

Group type: EXPERIMENTAL
Intervention: Spironolactone with modified extent and rate of absorption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical analysis using two-way MANOVA of statistical moments of urinary excretion profiles of canrenone
Number of subjects: 0
Study: 31140569

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT) program, 42 min per day, 5 days per week, over 10 weeks (35 hr total)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Active Control (AC), casual computer games, same duration as CT
Number of subjects: 68
Study: 29190126

Group type: EXPERIMENTAL
Intervention: Health news story with intrinsic features of stigma messages
Number of subjects: 200

Group type: COMPARATOR
Intervention: Health news story without intrinsic features of stigma messages
Number of subjects: 200
Study: 30135836

Group type: EXPERIMENTAL
Intervention: Internet intervention for depression (EVIDENT)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Population-based sample (DEGS1)
Number of subjects: 1013
Study: 26068325

Group type: EXPERIMENTAL
Intervention: Traditional training group (TG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Maturational training group (MG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 120
Study: 24927164

Group type: EXPERIMENTAL
Intervention: Flowable hemostatic matrix (FLOSEAL, Baxter Healthcare Corporation)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Non-flowable topical hemostats (SURGICEL Nu-Knit, Ethicon-Johnson & Johnson; GELFOAM, Pfizer)
Number of subjects: 600
Study: 22819864

Group type: EXPERIMENTAL
Intervention: Enoxaparin (4000 IU/day, subcutaneously for 48 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 70
Study: 19854334

Group type: EXPERIMENTAL
Intervention: Educational program consisting of a 15-minute presentation
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Use of a syringe rather than vacutainer
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Venipuncture for blood sampling
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Arterial sampling
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Sample volume
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Interval from sampling to analysis
Number of subjects: 204
Study: 17365948

Group type: EXPERIMENTAL
Intervention: Fat-free mass (FFM) protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total-body mass (TBM) protocol
Number of subjects: 0
Study: 15339769

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring
Number of subjects: 80

Group type: COMPARATOR
Intervention: 20 microg ethinyl estradiol oral contraceptive pill
Number of subjects: 80
Study: 11993702

Group type: EXPERIMENTAL
Intervention: Meta-analysis of therapeutic interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis of diagnostic test accuracy
Number of subjects: 0
Study: 9581698

Group type: EXPERIMENTAL
Intervention: Ribavirin (up to 1.2 g daily for 24 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Interferon alfa (3 MU three times a week for 24 weeks)
Number of subjects: 30
Study: 7951479

Group type: EXPERIMENTAL
Intervention: Breakfast preload sweetened with aspartame (300 kcal)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Breakfast preload sweetened with sucrose (300 kcal)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Breakfast preload sweetened with aspartame and supplemented with maltodextrin (700 kcal)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-energy breakfast preloads
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-energy breakfast preloads
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Obese women
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lean women
Number of subjects: 24
Study: 3182481

Group type: EXPERIMENTAL
Intervention: Inhaled codeine (50 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled morphine (10 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral codeine (60 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intravenous morphine (0.15 mg/kg)
Number of subjects: 13
Study: 30909248

Group type: EXPERIMENTAL
Intervention: 20Hz rTMS
Number of subjects: 52

Group type: COMPARATOR
Intervention: 1Hz rTMS
Number of subjects: 52
Study: 28052884

Group type: EXPERIMENTAL
Intervention: Vitamin B-12 toothpaste
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 76
Study: 25803666

Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) exercise program
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Pilates exercise program
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196
Study: 23631513

Group type: EXPERIMENTAL
Intervention: CO2 fractional laser therapy
Number of subjects: 15
Study: 21875440

Group type: EXPERIMENTAL
Intervention: IMSI
Number of subjects: 57

Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 57
Study: 19289711

Group type: EXPERIMENTAL
Intervention: Budesonide respule therapy
Number of subjects: 9
Study: 17942013

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Speed-of-processing training
Number of subjects: 2802

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 2802
Study: 15189292

Group type: EXPERIMENTAL
Intervention: GAS isolates differentiated by Vir typing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GAS isolates differentiated by emm typing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Most prevalent emm type
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison of emm type distribution
Number of subjects: 40
Study: 15296684

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural cardiac rehabilitation programme (12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting treatment group
Number of subjects: 0
Study: 10537964

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 to 20 mg/day (n = 551)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Haloperidol 5 to 20 mg/day (n = 266)
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 to 20 mg/day
Number of subjects: 817

Group type: COMPARATOR
Intervention: Haloperidol 5 to 20 mg/day
Number of subjects: 817
Study: 7744944

Group type: EXPERIMENTAL
Intervention: Bipolar prosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unipolar prosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internal fixation
Number of subjects: 0
Study: 2248819

Group type: EXPERIMENTAL
Intervention: Nimodipine 0.5 micrograms kg‐1 min‐1
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 6767826

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 39

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 39